Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A deep neural network for automatic prediction of mouse behavior from ultrasonic vocalizations emitted during social interaction test.

Scientific reports·2026
Same author

Unraveling the dual roles of MICAL2 in skeletal muscle physiology and fusion negative rhabdomyosarcoma tumor progression.

Cell death & disease·2026
Same author

Antiproliferative effects of HIV integrase strand transfer inhibitors in experimental models for cancer research: A narrative review.

The Journal of pharmacology and experimental therapeutics·2026
Same author

Multi-omics analyses identify EZH2 as a central driver in rhabdomyosarcoma radioresistance and highlight Tazemetostat as an effective radiosensitizer in vitro and in vivo.

Cell death & disease·2026
Same author

Penetratin Decoration Increases RNAi Silencing Effects of Polymeric Carriers.

Chemistry of materials : a publication of the American Chemical Society·2026
Same author

Biotin-Decorated Inulin-Based Polymeric Micelles Unveil Their Dual-Targeting Ability for the Potential Treatment of Glioblastoma Multiforme through the <i>In Vitro</i> and <i>In Vivo</i> Investigations.

Molecular pharmaceutics·2026

Related Experiment Video

Updated: Sep 15, 2025

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
09:02

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

2.8K

Advances in Nanoparticle Systems for Targeted Therapy against Glioblastoma Multiforme.

Paola Riccobelli1, Benjamin Franklin Pierce2, Emanuela Fabiola Craparo3

  • 1Department of Molecular and Translational Medicine, University of Brescia, Viale Europa 11, 25123 Brescia, Italy.

International Journal of Pharmaceutics
|July 14, 2025
PubMed
Summary

Innovative nanotechnology systems offer new hope for Glioblastoma Multiforme (GBM) treatment. Dual-Targeting Systems (DTSs) show promise for crossing the Blood-Brain Barrier (BBB) and targeting GBM cells effectively.

Keywords:
Blood-Brain BarrierBlood-Brain Tumor BarrierDual-Targeting Lipid-based NanoparticlesDual-Targeting Polymeric-based NanoparticlesGlioblastoma MultiformeHybrid Systems

More Related Videos

Author Spotlight: Multimodal Imaging Strategies for Optimizing Drug Delivery and Early Detection in Glioblastoma Treatment
07:25

Author Spotlight: Multimodal Imaging Strategies for Optimizing Drug Delivery and Early Detection in Glioblastoma Treatment

Published on: March 1, 2024

2.5K
Contrast Ultrasound Targeted Treatment of Gliomas in Mice via Drug-Bearing Nanoparticle Delivery and Microvascular Ablation
14:10

Contrast Ultrasound Targeted Treatment of Gliomas in Mice via Drug-Bearing Nanoparticle Delivery and Microvascular Ablation

Published on: December 15, 2010

16.1K

Related Experiment Videos

Last Updated: Sep 15, 2025

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
09:02

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

2.8K
Author Spotlight: Multimodal Imaging Strategies for Optimizing Drug Delivery and Early Detection in Glioblastoma Treatment
07:25

Author Spotlight: Multimodal Imaging Strategies for Optimizing Drug Delivery and Early Detection in Glioblastoma Treatment

Published on: March 1, 2024

2.5K
Contrast Ultrasound Targeted Treatment of Gliomas in Mice via Drug-Bearing Nanoparticle Delivery and Microvascular Ablation
14:10

Contrast Ultrasound Targeted Treatment of Gliomas in Mice via Drug-Bearing Nanoparticle Delivery and Microvascular Ablation

Published on: December 15, 2010

16.1K

Area of Science:

  • Nanotechnology
  • Oncology
  • Biomedical Engineering

Background:

  • Glioblastoma Multiforme (GBM) presents a significant challenge in neuro-oncology due to poor patient prognosis and limited therapeutic options.
  • Current GBM therapies face challenges in efficacy and translation to clinical practice.
  • Nanotechnology offers novel strategies to overcome these limitations.

Purpose of the Study:

  • To provide new perspectives on nanotechnology systems for Glioblastoma Multiforme (GBM) treatment.
  • To analyze the feasibility and efficacy of various nanoparticle architectures for GBM therapy.
  • To highlight the potential of Dual-Targeting Systems (DTSs) for overcoming the Blood-Brain Barrier (BBB) and targeting GBM cells.

Main Methods:

  • Review of current Glioblastoma Multiforme (GBM) therapies and their limitations.
  • Analysis of diverse nanoparticle architectures for GBM treatment potential.
  • Focus on Dual-Targeting Systems (DTSs) with specific attention to targeting ligands and Blood-Brain Barrier (BBB) penetration.
  • Summary of challenges and future perspectives for nanomedicine in GBM treatment.

Main Results:

  • Nanotechnology systems demonstrate significant potential for Glioblastoma Multiforme (GBM) treatment.
  • Dual-Targeting Systems (DTSs) are particularly promising, designed to cross the Blood-Brain Barrier (BBB) and target GBM cells.
  • Various nanoparticle architectures show feasibility for translation and efficacy.
  • Challenges in multitargeted systems require further investigation for clinical translation.

Conclusions:

  • Nanotechnology holds promise for developing innovative Glioblastoma Multiforme (GBM) treatments.
  • Further research into Dual-Targeting Systems (DTSs) and overcoming translational barriers is crucial.
  • Deeper understanding of GBM molecular mechanisms will inform the design of next-generation nanotherapeutics.